8 Results for "

BIM peptide

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "BIM peptide" in MCE Product Catalog:

1
1 Cited Publications
Referencia número: HY-P1527
No. CAS: 505070-06-4
Target:  

Bcl-2 Family

Áreas de investigación:  

Others

Bim BH3 is a biological active peptide. (This Bim peptide belongs to the pro-apoptotic Bcl-2 family of proteins.)
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-103277A
Pureza:  96.20%
Target:  

Bombesin Receptor

Áreas de investigación:  

Neurological Disease Metabolic Disease

BIM 23042 TFA, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?(HY-P0241), ICI 216140 and DPDM-bombesin ethylamide-induced Ca 2+ release .
loading...
    loading...
Referencia número: HY-P1889
No. CAS: 721885-31-0
Target:  

Bcl-2 Family

Áreas de investigación:  

Inflammation/Immunology

Bim BH3, Peptide IV is a 26-residue peptide from BH3-only protein Bim, which belongs to the pro-apoptotic group of the Bcl-2 family of proteins .
loading...
    loading...
Referencia número: HY-P0039
No. CAS: 136207-23-3
Target:  

Bombesin Receptor

Áreas de investigación:  

Cancer

BIM-26226 is a selective gastrin-releasing peptide receptor (GRPR) (IC50 = 6 nM) and bombesin receptor (BN receptor) antagonist. BIM-26226 antagonizes BN- or GRP-stimulated amylase release with IC50 values of 0.3 nM and 0.2 nM, respectively. BIM-26226 is specific for the GRP-preferring BN receptor subtype with no interference with GRP receptor system. BIM-26226 can induce the synthesis of somatostatin receptor but has no significant effect on tumor growth .
loading...
    loading...
Referencia número: HY-103277
No. CAS: 111857-96-6
Target:  

Bombesin Receptor

Áreas de investigación:  

Neurological Disease Metabolic Disease

BIM 23042, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?(HY-P0241), ICI 216140 and DPDM-bombesin ethylamide-induced Ca 2+ release .
loading...
    loading...
Referencia número: HY-P1889A
Target:  

Bcl-2 Family

Áreas de investigación:  

Inflammation/Immunology

Bim BH3, Peptide IV TFA is a 26-residue peptide from BH3-only protein Bim, which belongs to the pro-apoptotic group of the Bcl-2 family of proteins .
loading...
    loading...
Referencia número: HY-P10984
No. CAS: 206536-96-1
FNIII14 is a β1-integrin inhibitory peptide. FNIII14 induces the conformational shift of β1-integrin from the active form to the inactive form, blocks integrin-mediated signaling pathways, disrupts the interaction between VLA-4 and fibronectin, inhibits the phosphorylation of FAK/Akt, suppresses cell adhesion, fibronectin fibril formation and chondrocyte proliferation, induces chondrocyte apoptosis and cartilage degeneration, upregulates the pro-apoptotic protein Bim, and binds to membrane-bound eEF1A. FNIII14 reversibly disrupts cell adhesion without reducing cell viability, accelerates adipocyte differentiation, and loosens tumor matrix architecture to enhance the permeability of nanotherapeutic agents. FNIII14 can be used in research related to neuroblastoma, pancreatic cancer, acute myeloid leukemia, colitis-associated colorectal cancer, osteoarthritis, and atherosclerosis .
loading...
    loading...
Referencia número: HY-187706
No. CAS: 951529-42-3
Target:  

Bcl-2 Family

Áreas de investigación:  

Cancer

CDL36 is a BAX inhibitor with an EC50 of 23.6 µM. CDL36 inhibits pro-apoptotic peptide-induced mitochondrial outer membrane permeabilization (MOMP). CDL36 exerts cytoprotective effects against Doxorubicin (HY-15142A)-induced cell death .
loading...
    loading...